Drug
Cyclopentolate Hydrochloride
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Mydriasis | 26 | 66.1 | 68.8 | signal |
| 2 | Uveitis | 25 | 60.3 | 62.7 | signal |
| 3 | Retinal Detachment | 17 | 60.2 | 61.8 | signal |
| 4 | Photophobia | 27 | 47.1 | 49.1 | signal |
| 5 | Intraocular Pressure Increased | 16 | 40.6 | 41.6 | signal |
| 6 | Eye Pain | 60 | 35.4 | 38.9 | signal |
| 7 | Eye Inflammation | 8 | 27.6 | 27.9 | signal |
| 8 | Osteopenia | 12 | 25.6 | 26.1 | signal |
| 9 | Ejection Fraction Decreased | 12 | 25.1 | 25.5 | signal |
| 10 | Ocular Discomfort | 8 | 24.0 | 24.3 | signal |
| 11 | Visual Acuity Reduced | 23 | 22.3 | 23.1 | signal |
| 12 | Glaucoma | 13 | 21.9 | 22.4 | signal |
| 13 | Ocular Hyperaemia | 31 | 21.6 | 22.6 | signal |
| 14 | Eye Disorder | 21 | 20.8 | 21.5 | signal |
| 15 | Grand Mal Convulsion | 6 | 20.8 | 21.0 | signal |
| 16 | Vitreous Floaters | 6 | 20.0 | 20.2 | signal |
| 17 | Haemorrhoids | 12 | 20.0 | 20.3 | signal |
| 18 | Presyncope | 14 | 18.8 | 19.2 | signal |
| 19 | Lacrimation Increased | 17 | 18.5 | 19.0 | signal |
| 20 | Conjunctivitis | 10 | 17.7 | 18.0 | signal |
| 21 | Eye Irritation | 29 | 16.9 | 17.7 | signal |
| 22 | Ataxia | 5 | 13.6 | 13.7 | signal |
| 23 | Blindness | 13 | 10.4 | 10.6 | signal |
| 24 | Drug Toxicity | 3 | 7.1 | 7.1 | signal |
| 25 | Device Use Issue | 3 | 5.6 | 5.7 | signal |